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Abstract
Women at high-risk for HIV acquisition often face challenges that hinder their retention in HIV prevention
trials. These same challenges may contribute to missed clinical care visits among HIV-infected women. This
article, informed by the Gelberg-Andersen Behavioral Model for Vulnerable Populations, identifies factors
associated with missed study visits and describes the multifaceted retention strategies used by study sites. HPTN
064 was a multisite, longitudinal HIV seroincidence study in 10 US communities. Eligible women were aged
18–44 years, resided in a census tract/zipcode with high poverty and HIV prevalence, and self-reported ‡ 1
personal or sex partner behavior related to HIV acquisition. Multivariate analyses of predisposing (e.g., substance
use) and enabling (e.g., unmet health care needs) characteristics, and study attributes (i.e., recruitment venue, time
of enrollment) identified factors associated with missed study visits. Retention strategies included: community
engagement; interpersonal relationship building; reduction of external barriers; staff capacity building; and ex-
ternal tracing. Visit completion was 93% and 94% at 6 and 12 months. Unstable housing and later date of
enrollment were associated with increased likelihood of missed study visits. Black race, recruitment from an
outdoor venue, and financial responsibility for children were associated with greater likelihood of attendance.
Multifaceted retention strategies may reduce missed study visits. Knowledge of factors associated with missed
visits may help to focus efforts.
Introduction
The HIV epidemic in the United States (US) is not ageneralized epidemic; rather, it is concentrated in sub-
populations as defined by geography, poverty, race/ethnicity,
and transmission mode.1 The burden of HIV in women has
grown substantially over the past 20 years; the proportion of
women newly diagnosed with AIDS has risen from 8% in
1985 to more than 23% in 2010.2,3 Women constitute roughly
one quarter of new HIV infections each year in the US; 85%
of those infections are acquired through heterosexual trans-
mission.4 Substantial racial disparities exist both for new HIV
infections and in HIV-related outcomes. In 2010, the rate of
new HIV infections (per 100,000 for the general female adult
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and adolescent population) among black/African-American
females was nearly 20 times the rate in white females.4
Moreover, black women living with HIV infection face sig-
nificant barriers to care and treatment5 and experience greater
AIDS-related mortality than other women.4
Inclusion of women and people of color in research stud-
ies has been mandated by the National Institutes of Health6
and is a key component to ensuring study results that are
generalizable to these populations.7 However, those consid-
ered most at-risk for HIV in the US may also be less likely to
enroll in HIV prevention and treatment trials, due in part to
restrictive eligibility criteria, researcher bias that certain in-
dividuals may be more difficult to retain, cultural and lan-
guage barriers, and/or a lack of trust on the part of the
potential study participants.8–16 Once enrolled, retention of
study participants is essential to study success and accurate
interpretation of study results. Notably, many of the same
factors associated with increased risk of HIV acquisition
among US women (e.g., poverty, race, drug and alcohol use,
unstable housing, and psychological distress17–19) are also
associated with missed study visits among HIV-uninfected
women in prospective HIV cohort studies.20–22 Substantial
attrition may lead to loss of study power, bias, and difficulty
in interpretation of study results,7 further hampering our
ability to not only define HIV incidence among women in the
US, but to also identify the key behavioral, sexual network,
and environmental characteristics that influence women’s
vulnerability to HIV acquisition. As a result, it is critical to
understand the factors that predict missed study visits so that
retention efforts may be tailored accordingly.
Prospective observational HIV cohort studies and longitu-
dinal vaccine preparedness studies (observational cohorts
which assessed interest in future trials, but did not include
vaccine administration as part of the study design) have had
varied success in retaining US women, with 12-month reten-
tion rates ranging from 67% to 92%.8,20–24 Limited data are
available regarding factors associated with missed study visits
among women enrolled in prospective HIV studies in the US.
The most notable example is the Women’s Interagency Study
(WIHS), a multisite prospective study of women and HIV in
the US established in 1993.25 Analysis of the second wave of
women enrolled indicated that, among HIV-uninfected par-
ticipants, temporary housing, depressive symptoms, moderate
alcohol consumption, use of crack/cocaine/heroin, and having
a primary care provider were associated with missed study
visits at 6 and 12 months of follow-up. In contrast, younger age
and employment were associated with greater visit attendance.
The relationship between recruitment site and visit attendance
varied.20 Analysis of past longitudinal vaccine preparedness
studies (which assessed interest in future trials, but did not
include vaccine administration as part of the study design)
enrolling men and women in the US have demonstrated sig-
nificant associations between gender, enrollment criteria met,
study site, frequency of moving, age, education, race/ethnicity,
unemployment, and unstable housing with loss to follow-
up.21–23 Similarly, women enrolled in HIV treatment trials
experience higher rates of antiretroviral therapy (ART) dis-
continuation than men.14–16 The most commonly cited reason
for discontinuation is loss to follow-up, though the reasons for
this loss to follow-up are unclear.14,16
Many of the same factors associated with missing study
visits among women at increased risk of HIV acquisition
have also been associated with missing clinical visits among
HIV-infected patients. Just as female gender, being a racial/
ethnic minority, psychological distress (e.g., depression),
drug use, and younger age, have all been associated with
missed study visits in prospective HIV cohort studies, these
factors have also been associated amongst HIV-infected pa-
tients with missing HIV medical appointments.5,26–28 Addi-
tional factors, including inadequate social support and lack of
health insurance, have also been identified as important
contributors to missing clinical visits in women living with
HIV, however it is not known whether such factors could also
play a role in study visit attendance. Missed medical ap-
pointments are associated with poorer health outcomes, in-
creased mortality, and higher viral loads, which have
important implications both for individual well-being and
HIV transmission to uninfected partners.29
The Gelberg-Andersen Behavioral Model for Vulnerable
Populations acknowledges that certain populations (e.g.,
homeless, substance users) may face specific vulnerabilities
and competing needs that may lead to significant barriers in
obtaining health care. The Gelberg-Andersen Behavioral
Model for Vulnerable Populations describes relationships be-
tween predisposing, enabling, and need (i.e., illness) factors
specific to vulnerable populations. As described by this model,
predisposing characteristics include factors that exist prior to
the perception of illness and include sociodemographics (e.g.,
age, gender, and education), as well as variables that reflect
vulnerability, such as psychological distress (e.g., depression)
and substance use. Enabling characteristics include factors that
may serve as facilitators or barriers to care, such as income,
health insurance, and competing needs (e.g., food insecurity).
This model has been applied successfully to predict health
service utilization (HSU) among homeless women,30,31 and
can be extended to women at enhanced risk for HIV in the US,
who share many of the characteristics associated with vul-
nerable populations (e.g., substance use, marginal housing,
psychological distress). This model has not previously been
used to assess the associations between predisposing and en-
abling factors and attendance of clinical trial visits.
The HIV Prevention Trials Network Study (HPTN 064),
Women’s HIV SeroIncidence Study (ISIS) was a multisite
prospective observational study designed to estimate the HIV
incidence among women living in areas of the US with
prevalent HIV and poverty, and to determine the feasibility of
retaining women recruited using venue-based sampling.17
The current analysis is guided by the Gelberg-Andersen
Behavioral Model for Vulnerable Populations,30 and (1) ex-
plores associations between baseline predisposing factors,
enabling factors, study attributes, and study visit attendance,
and (2) describes retention strategies used by study sites.
Methods
Eligibility
Study participants were women between the ages of 18–44
years, who resided in either census tracts or zip codes with
higher levels of HIV prevalence and poverty than the sur-
rounding tracts. In addition, to be eligible, women had to
report at least one personal and/or partner characteristic as-
sociated with greater risk of HIV acquisition (e.g., substance
use, history of incarceration, exchange of sex for commodi-
ties). Women were excluded from participating if they
RETENTION OF WOMEN AT RISK FOR HIV 207
reported a history of previous positive results on an HIV test,
current HIV prevention trial enrollment, current or past par-
ticipation in an HIV vaccine trial, or anticipated absence for
more than 2 consecutive months during follow-up. Women
were recruited from community locations using venue-based
sampling techniques. The overall study design and method-
ology has been described elsewhere.17,32
Study procedures
Women were followed for 6 or 12 months, depending on
date of enrollment. Participants received HIV rapid testing
and audio computer-assisted self-interviews (ACASI) at
baseline and at 6-month intervals for up to 12 months. All
participants received monthly phone calls to update locator
information. Women were compensated for both in-person
follow-up visits and phone locator-update calls. The amount
of compensation varied by site and was approved by local
Institutional Review Boards.
Sites
HPTN 064 participants were enrolled from one of ten study
communities across six geographic areas. These sites included:
New York City, New York (The Bronx and Harlem), Newark,
New Jersey (North and South Newark), Washington, DC,
Baltimore, Maryland, North Carolina (Durham and Wake
Counties), and Atlanta, Georgia (Atlanta and Decatur). A
Certificate of Confidentiality was obtained for the study and
study sites obtained local Institutional Review Board ap-
proval prior to initiation of study activities.
Definitions of visit nonattendance and retention
The primary outcome of interest for these analyses was
study visit attendance. A missed study visit was defined as any
in-person study visit that was not completed within the al-
lowable follow-up visit window. Overall study retention was
defined as the proportion of women completing the final
scheduled in-person study visit within the allowable study
window. Using these definitions, a participant enrolled in the
12-month cohort could miss a visit at 6 months and still be
considered retained if the 12-month visit was completed. The
study visit window was 12 weeks on either side of the visit for
ongoing follow-up visits. Participants who completed their
final study visit prior to the end of site follow-up activities
were considered retained.
Retention strategies
Study sites used a combination of techniques with the goal of
maintaining high rates of study visit completion and to prevent
loss to follow-up. All sites implemented a core set of retention
strategies designed to develop trusting relationships with study
communities and the participants themselves and to reduce
barriers to visit completion. These strategies were informed by
available literature, HPTN and study site best practices, and
ethnographic assessments.16,20,33–35 Sites developed additional
techniques in response to their participant population (Table 1).
Community engagement and retention methods were adapted
throughout study implementation in response to observations
and ongoing feedback from participants regarding barriers to
visit attendance. Strategies were documented throughout
the study and aligned with one of five broader categories:
community engagement; interpersonal relationship building;
reduction of external barriers to participation; staff capacity
building; and external tracing approaches.
Community engagement
In accordance with HPTN standard operating procedures, a
study-wide Community Working Group (CWG) with repre-
sentatives from each study site was established early in study
development. In addition, each site had its own Community
Advisory Board (CAB). The CWG and CABs were consulted
on a regular basis (e.g., at least monthly meetings) and re-
viewed study documents during protocol development, study
implementation, and results dissemination. Community col-
laborators identified potential design pitfalls early in study
development during a 3-day facilitated protocol review and
provided ongoing expertise and consultation throughout the
study. The study logo and associated branding was developed
through a community-based logo contest and selected through
collaboration between the study protocol and site teams and
the CWG.
Prior to study initiation, staff conducted an ethnographic
review of census tracts/zip codes included in each study
community. Each site developed a tailored approach to con-
ducting ethnography based on consultation with local experts
and community advisory boards. Ethnographic data collection
activities included walking and driving through potential tracts
(e.g., ‘‘windshield tours’’), informal communication with
community partners, advisory boards, residents, and business
owners, and in some cases, brief interviews and focus groups
with women and other key informants. Through this process,
study staff developed ongoing partnerships with local com-
munity organizations and key community stakeholders (e.g.,
community advocates, individuals identified as respected
neighborhood members through interactions and communi-
cations with community members during ethnographic as-
sessments).36 During both the recruitment and retention stages,
site staff maintained an active presence at community events
and in day-to-day activities by purchasing bus ads, patronizing
community businesses, and volunteering at community events.
In addition, some staff lived or worked in the study commu-
nities and were already familiar with the area. Site staff also
regularly revisited recruitment venues and posted study flyers
in order to increase visual reminder cues for participants.
Interpersonal relationship-building
Relationship-building began in the early stages of study
interaction and included: collection and regular updates of in-
depth locator information (including the use of nicknames and
aliases), monthly locator update phone calls, letters, and home
and ‘‘hang-out’’ venue visits, birthday, holiday, ‘‘we miss
you’’ and thank you cards, study branded items (e.g., t-shirts,
pens, key chains), and participant appreciation retention events
(e.g., spa days, catered lunches with female speakers). Sites
obtained advance permission to contact friends and family,
and in some cases obtained permission to contact participants
through texting and social media, such as Facebook.
Reduction of external barriers to participation
Study visits were designed with the goal of reducing par-
ticipant burden, and included pre-planning of study activities



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































to ensure shorter visits (standard follow-up visits lasted be-
tween 30 and 45 min), site staff availability on nights and
weekends, and informal childcare (e.g., toys and snacks for
children), community-based study visit sites, and the use of
mobile vans (to locate participants and to conduct follow-up
visits). Same day screening and enrollment visits were offered
to participants; in some cases, site staff escorted participants
from directly from the recruitment venue to the clinic in an
effort to reduce barriers to enrollment. Each site developed a list
of community resources (e.g., social services, food pantries,
woman well-care) that was made available to participants at
each visit. Referrals were provided as needed. Participants were
compensated for time and travel expenses for each in-person
visit and for each monthly phone locator update phone call.
Staff capacity building
HPTN 064 consisted of 10 communities across six geo-
graphic regions. A minimum of two staff members were re-
quired for all retention activities to ensure the safety of study
staff. Study field staff were predominantly women of color and
were experienced in community-based approaches to clinical
research. Throughout the study, regular calls, meetings, and
trainings facilitated ongoing site capacity building and infor-
mation sharing. In particular, site staff participated in biweekly
or monthly (depending on the phase of study implementation)
cross-site team calls where they shared successes and chal-
lenges, and discussed potential strategies accordingly. All
study teams participated in a 1-day Retention Workshop, where
they presented actual case studies and discussed approaches for
locating difficult to contact participants. Site staff consulted
each other over the phone as needed, and in some cases, visited
sites with high retention rates to share best practices.
The HPTN 064 study population was highly mobile and
moved and changed phone numbers frequently. When pos-
sible, study sites transferred responsibility for follow-up of
participants who moved from one study catchment area into
another. A total of eight inter-site transfers took place
throughout the study, limiting loss to follow-up due to out of
state relocation.
Participant tracing
Detailed locator information was updated monthly, as dic-
tated by protocol-required phone calls. Locator forms included
information on participants’ own contact information (e.g.,
home, phone, email, social media identities), as well as contact
information for family, friends, frequent hang-outs, and the
names/nicknames to use with each contact. Staff obtained
advance permission to contact participants using multiple
modalities. Participant tracing activities included use of phone,
text-message, mail, online, and in person locator contacts
(phone calls, email, social media, visiting participant home
and hang-outs), as well as monitoring of online jail and prison
databases. In addition, following the completion of participant
follow-up, each site searched online death registries, such as
the Social Security Death Index (SSDI), to determine if any
participants who missed their final study visit were deceased.
Analysis
Continuous variables were summarized using medians,
and interquartile ranges. Categorical variables were tabulated
using frequency and percentage. Multivariate models of
baseline factors that predicted missed follow-up visits at
6 and 12 months were based on log-binomial regression
(with robust variances). Covariate selection was informed by
the Gelberg-Andersen Behavioral Model for Vulnerable
Populations and aligned with enabling and predisposing
factors outlined by the model (Table 2),31 and review of
relevant literature identifying factors associated with missed
visits.8,20,21 The primary outcome (utilization measure) was
defined as a missed visit (yes/no) at 6 or 12 months. The
following independent variables were assessed for their as-
sociation with missed study visits: (1) predisposing charac-
teristics (within the last 6 months): demographic variables
[age (categorical, 18–26, 27–33, 34 + ), black race (yes/no),
education (categorical, less than high school, high school or
greater), symptoms of PTSD, defined as a score of 3 or
greater on the Primary Care PTSD screener (yes/no),37
symptoms of depression, defined as a score of 7 or greater on
a shortened CES-D scale (yes/no),38 history of childhood
abuse (yes/no), current abuse, defined of a report of one or
more emotional, sexual, physical abuse or feeling unsafe
(yes/no), sex exchange, defined as exchange of sex for drugs,
money, shelter, or necessities (yes/no) and concurrency [di-
rect (yes/no), indirect (yes/no)], frequency of drug use (cat-
egorical, weekly/daily, monthly/less than monthly, or no use
of cocaine, amphetamines, inhalants, sedatives, hallucinogens,
and/or opioids), binge drinking (categorical, weekly/daily,
monthly/less than monthly, or no consumption of four or more
drinks in a given time period)], and current housing (cate-
gorical, home rented/owned by participant, home rented/
owned by spouse/partner, parent’s house/someone else’s
house or apartment, halfway house/treatment center, homeless
shelter, motel/hotel/boarding house, street/park/abandoned
building/car, other), food insecurity (yes/no), financial re-
sponsibility for children (ordinal, 0, 1, ‡ 2), social support
from one or more friends (yes/no); (2) enabling characteristics
(within the last 6 months): forgone care, defined as unmet
health or medical care needs (yes/no), and self-reported history
of an STI (yes/no), (3) study attributes: recruitment location
(categorical, commercial venue, outdoor venue, social service
organization, public housing, special event, other public space,
spaces that serve alcohol), and date of enrollment relative to
site initiation of recruitment (continuous).
All variables were assessed for the previous 6 months, with
the exception of demographics, current housing situation, and
history of childhood abuse. Each covariate was fit into a
univariate model and factors that were significant at the 0.1
level were included in a multivariate model. Age, substance
use, and recruitment venue were forced into the multivariate
model. Relative risks and 95% confidence intervals are re-
ported. All analysis was done with SAS version 9.2 (SAS
Inc., Cary, NC).
Results
A total of 2099 participants were enrolled for 6 or 12
months of follow-up. Study participant baseline characteris-
tics are in Table 2. The majority of participants were black
(86%). The median age was 29 years. Thirty-seven percent
had less than a high school education, and 44% percent re-
ported an annual income of $10,000 or less. Baseline binge
drinking and illicit substance use in the last 6 months was
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Table 2. Participant Baseline Characteristics (in Previous 6 Months)










Less than high school education 777 (37%)
High school or greater 1322 (63%)
Physical, emotional, sexual abuse, and/or feeling unsafea 811 (39%)
Childhood abuseb 934 (44%)
Drug usec
Non-user 1887 (57%)
Monthly/less than monthly use 379 (18%)
Daily/weekly use 459 (22%)
Alcohol used
Non-user 767 (37%)
Monthly/less than monthly use 802 (38%)
Daily/weekly use 498 (24%)
Symptoms indicative of depression38 (score ‡ 7)e 692 (33%)
Symptoms indicative of PTSD37 (score ‡ 3)f 600 (29%)
Direct concurrency (participant)g 776 (37%)
Indirect concurrency (partner) 763 (36%)
Sex exchangeh 776 (37%)
Housing stabilityl
A home that you own or rent yourself 832 (40%)
A home that your spouse/partner owns or rents 173 (8%)
Parent’s house/someone else’s house or apartment 707 (34%)
Halfway house or treatment center 43 (2%)
Homeless shelter 167 (8%)
Motel, hotel, boarding house 31 (1%)
Street, park, abandoned building, car, etc. 15 (1%)
Other 101 (5%)
Enabling characteristics
Forgone health carei 417 (20%)
Self-reported STIj 232 (11%)
Reported food insecurityk 971 (46%)
Number of children financially responsible form
0 974 (47%)
1 465 (22%)
‡ 2 644 (31%)
Study attributes
Recruitment venue
Retail space 388 (18%)
Outdoor location 1215 (58%)
Social service organization 268 (13%)
Public housing 80 (3%)
Special event 66 (3%)
Public space (e.g., library, court, church, public transport) 69 (3%)
Spaces that serve alcohol 13 (1%)
aMissing: n = 20 (1%); bMissing: n = 29 (1%); cMissing: n = 74 (4%); dMissing: n = 32 (2%); eMissing: n = 157 (7%); fMissing: n = 52
(2%); gMissing n = 9 ( < 1%); hMissing n = 21 (1%); iMissing n = 3 ( < 1%); jMissing n = 33 (2%); kMissing n = 27 (1%); lMissing n = 30
(1%); mMissing n = 16 (1%).
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high; 62% reported binge drinking and 35% reported illicit
substance use (excluding cannabis). Thirty-nine percent
reported emotional, physical, or sexual abuse or feeling
unsafe, in the past 6 months. Condom use at last sex was low
(18%). A total of 472 participants were enrolled in the
6-month cohort and 1627 were enrolled in the 12-month
cohort. Participant visit completion was 93% at 6 months
and 94% at 12 months. Twenty-seven women did not attend
the 6-month visit but completed the 12-month visit. Overall
study retention was 92%. Ten participants died during
follow-up (0.61% per year). Reasons for missed visits are
described in Table 3.
Baseline predisposing characteristics (within the 6 months
prior to enrollment) significantly associated ( p < 0.05) with an
increased likelihood of a missed visit in univariate analysis
were indirect (partner) concurrency, symptoms of PTSD, so-
cial support, and abuse. Enabling characteristics significantly
associated ( p < 0.05) with an increased likelihood of a missed
visit included unstable housing (halfway house/treatment
center, shelter, motel, or homeless). Later enrollment in the
cohort (study attribute) was also associated with increased
likelihood of via missed visit ( p < 0.05). In contrast, black race
(predisposing) and financial responsibility for one or more
children in the past 6 months (enabling) were associated with
an increased likelihood of visit attendance ( p < 0.05). In
multivariate analysis, unstable housing (specifically halfway
house/treatment center or being homeless) and later enroll-
ment remained statistically significantly associated with in-
creased risk of a missed visit, while black race, outdoor
recruitment venue, and financial responsibility for one or more
children in the past 6 months remained associated with an
increased likelihood of visit attendance (Table 4).
Discussion
HPTN 064 was designed to determine the feasibility of
recruiting and retaining women at increased risk of HIV ac-
quisition in the United States. One in 300 women in the co-
hort acquired HIV annually,17 which is substantially higher
than the estimates of HIV incidence in US black women of a
similar age,39 demonstrating that the study did recruit and
enroll women at risk of HIV. HPTN 064 was the first study to
enroll women at risk of HIV acquisition in the US using
venue-based sampling (VBS) exclusively.32 Although re-
cruitment of women from community-based settings has
been identified as a possible barrier to retention in longitu-
dinal cohort studies, the overall retention rate was 92%,
demonstrating that it is possible to retain women at high risk
for study discontinuation and at enhanced risk of HIV ac-
quisition. HPTN 064 retention strategies were designed to
engage the community, build trust with study participants,
and to reduce external barriers to study participation. Site
collaborations and capacity-building throughout im-
plementation, combined with appropriate allocation of re-
sources, allowed staff to adapt to retention challenges and
develop creative approaches to encourage high rates of study
participation. External tracing allowed staff to identify par-
ticipants who were deceased or incarcerated.
HPTN 064 was an observational cohort study and did not
include a control group, limiting our ability to assess casual
relationships between retention strategies (positive or nega-
tive) and visit attendance. However, the HIV Vaccine Trial
Network (HVTN) conducted HVTN 906, a study designed to
identify a cohort of US women a high risk of HIV infection
during roughly the same time period as HPTN 064. This study
was conducted in three urban areas (Philadelphia, Chicago,
New York City) and similar to HPTN 064, enrolled women
based on geographic, personal, and sex partner risk criteria.24
Both studies found a comparable HIV incidence (0.31% in
HVTN 906 vs. 0.32% in HPTN 064).17,40 HVTN 906 retention
strategies have not been described in the literature, however,
reported visit completion of women enrolled into HVTN 906
was 86% at 6 months and 83% at 12 months. Comparisons
between HPTN 064 and HVTN 906 should be interpreted with
caution; however, it is possible that the intensive retention
efforts applied in HPTN 064 contributed to the higher rates of
visit attendance (93% at 6 months, 94% at 12 months).
There is a growing appreciation of the role of community
engagement as a critical element of study implementation,
and in recruitment and retention in particular.41–45 An early
vaccine preparedness study in New York designed to assess
the feasibility of recruiting and retaining women at risk of
HIV acquisition from heterosexual contact reported 67%
retention at 12 months follow-up. The retention strategies
reported included collection of locator information, incen-
tives, mail and phone appointment reminders, home visits,
and street outreach. This same site later achieved 92%
follow-up in a similar cohort at 12 months follow-up,22,23
which they attributed to enhanced retention strategies, in-
cluding a focus on community involvement. Community
engagement was a cornerstone of the HPTN 064 study and
study staff were an active presence in study communities.
Women enrolled in HPTN 064 reported extreme poverty,
low education levels, prevalent abuse, and high baseline
Table 3. Reported Reasons for Study Visit Nonattendance
Month 6 visit (n = 2099) Month 12 visit (n = 1627)
Missed visita 139/2099 (7%) 94/1627 (6%)
Reason visit was missed
Unable to contact participant 102/139 (73%) 64/94 (68%)
Participant refused visit 4/139 (3%) 2/94 (2%)
Participant incarcerated 15/139 (11%) 9/94 (10%)
Participant admitted to a health care facility 2/139 (1%) 3/94 (3%)
Participant withdrew from the study 4/139 (3%) 0/94 (0%)
Other 12/139 (9%) 16/94 (17%)
aParticipant death was considered an endpoint for the study and is not considered a missed visit.
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alcohol and substance use. The confluence of these factors
highlights the vulnerability and multilevel needs present
among many women living in areas with prevalent HIV and
poverty. The Gelberg-Andersen Behavioral Model for Vul-
nerable Populations provides a valuable framework through
which to explore predisposing and enabling characteristics
associated with visit attendance. For women who become
HIV-infected, these same factors which serve as barriers or
facilitators to study visit attendance are likely to also apply to
their likelihood of HIV medical care visit attendance.16
Knowledge of characteristics that predict missed visits,
as well as those that are protective, may help staff focus
Table 4. Multivariate Analysis of Baseline Characteristics and Visit Nonattendance




27–33 1.293 [0.875, 1.91] 0.1975
34 + 0.847 [0.553, 1.299] 0.4471
Race
Non-blacka
Black 0.614 [0.428, 0.883] 0.0084b
Education
Less than high schoola
High school or greater 0.820 [0.610, 1.102] 0.1887
Any indirect concurrency in past 6 months
Noa
Yes 1.243 [0.923, 1.674] 0.1519
Symptoms indicative of PTSD37
Noa
Yes 1.016 [0.724, 1.424] 0.9279
Drug use
Non-usera
Monthly/less than monthly use 0.838 [0.548, 1.283] 0.4162
Daily/weekly use 0.963 [0.642, 1.444] 0.8557
Physical, emotional, sexual abuse, and/or feeling unsafe
Noa
Yes 1.338 [0.980, 1.827] 0.0665
Childhood abuse
Noa
Yes 1.019 [0.738, 1.406] 0.9103
Housing
Home rent/own selfa
A home that your spouse/partner owns or rents 1.149 [0.605, 2.183] 0.6705
Parents house/someone else’s house or apartment 1.190 [0.775, 1.828] 0.4272
Halfway house or treatment center 2.100 [1.024, 4.308] 0.0429b
Homeless shelter 1.615 [0.921, 2.832] 0.0943
Motel, hotel, boarding house 1.491 [0.489, 4.544] 0.4820
Street, park, abandoned building, car 2.829 [1.094, 7.316] 0.0319b
Other 1.183 [0.593, 2.358] 0.6332
Enabling characteristics
Number of children financially responsible for
0a
1 0.397 [0.243, 0.646] 0.0002c




Park/street location 0.620 [0.420, 0.914] 0.0157b
Social service organization 0.616 [0.374, 1.015] 0.0572
Public housing 0.354 [0.086, 1.466] 0.1522
Special event 1.023 [0.453, 2.307] 0.9568
Public space 0.678 [0.283, 1.622] 0.3826
Spaces that serve alcohol 1.314 [0.364, 4.743] 0.6769
Time since first participant at site enrolled ( + 30 days) 1.097 [1.040, 1.157] 0.0007c
aReference Group bp value < 0.05, cp value < 0.001.
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retention efforts and to identify participants in need of en-
hanced outreach.
Similar to past studies, this study found that less stable
housing and non-black race were associated with missed
visits.8,20 In contrast to past studies, age, education, sub-
stance and alcohol use were not significantly associated
with missed visits in univariate and multivariate analysis.
Symptoms of PTSD and history of abuse were significant in
univariate analysis, but this relationship faded in multivariate
analysis.8,20,21 These results contrast past research, which has
found associations between age, education, substance and al-
cohol use, psychological distress, and missed study visits.
Although the absence of a comparison group makes it difficult
to assess causality between retention efforts and study atten-
dance, it is possible that the intensive retention strategies de-
scribed above reduced attrition among these high risk groups.
Housing instability, which remained statistically significant in
the multivariate analysis, may be a reflection of the interaction
of complex social forces such as substance use, abuse, and
financial instability.46,47 Studies enrolling women who are
marginally-housed may consider developing partnerships with
and providing referrals to organizations that address housing
needs, substance use, etc., while also identifying ways to reach
women independent of their address, such as through alter-
native contacts and/or identification of frequent ‘‘hang-out’
spots.
Past studies have not assessed the relationship between
recruitment modality (e.g., street outreach, referral) and
retention. However, in this study, recruitment at an outdoor
venue (park or street location) was associated with an in-
creased likelihood of visit attendance, highlighting that it is
possible to retain women recruited from nontraditional
venues, and from community-based settings more gener-
ally. Women enrolled during early study implementation
were more likely to complete study visits than those en-
rolled later in time. This is likely a reflection of the fact that
participants could complete their final study visit up to the
date of study closure (HIV seroincidence was the primary
endpoint of the study), thereby increasing the length of the
final study visit window and the amount of time available to
locate difficult to contact participants. Although wide visit
windows may not be appropriate for all study designs, this
finding highlights the need for maximizing study visit
windows when feasible.
A small, but noteworthy proportion of visit nonattendance
was due to known incarceration (11% and 10% at 6 and 12
months, respectively). This is a likely under-representation
of total incarcerations throughout study implementation as
some women were likely incarcerated and released in the
time between biannual in-person study visits. Future studies
may consider obtaining necessary ethics and funder ap-
provals to contact participants and establishing partnerships
with jails and prisons, so that participants can be contacted
and, ideally, followed during periods of incarceration. This
approach has been identified as an important strategy in
achieving high follow-up rates in longitudinal studies of
drug abusers.33,35
Studies suggest that women view monetary compensation
as a benefit of study participation and that they believe this
compensation should be reflective of the time and risk as-
sociated with participation.48 The exact compensation varied
by site and ranged from 35 to 50 dollars for in-person study
visits and 10 to 15 dollars for locator-update phone calls.
Fifty-five percent of women reported annual incomes equal to
or less than $20,000. Although baseline income and reported
food insecurity were not found to be significantly associated
with missed visits in this analysis, given the relatively short
length of study visits and the minimally-invasive nature of
the follow-up study (blood draws and ACASI interviews), it
is likely that financial compensation reduced barriers to ini-
tial participation and provided some encouragement for
continued participation.
Although HIV treatment trials have found associations
between being a primary caregiver and study discontinua-
tion,14 in contrast, this study was the first to identify financial
responsibility for children as increasing the probability of
visit attendance. Once enrolled, it is possible that women
with children may have had additional health motivations to
attend study visits, such as an increased interest in HIV
voluntary counseling and testing and community referrals,
and/or greater reliance on financial compensations.49 It is
possible that the use of nontraditional working hours, the
provision of informal childcare, and community-based clinic
locations may have reduced barriers to participation.
However, a focus on financial compensation would mini-
mize the larger potential impact of HPTN 064 on the lives of
many of the participants enrolled. Women in treatment trials
have cited staff support as an important factor in study
completion.14 Recognizing the geographic diversity and un-
ique life situations of each participant, study sites used a
combination of techniques to maintain high rates of study
visit completion and to prevent subsequent loss to follow-up,
many of which were relational in nature. There were nu-
merous accounts from project staff of how the participants
viewed the study as a positive motivation for change in their
lives and analysis suggests that women increased condom use
over the study follow-up period, despite the fact that it was an
observational study.17 As one participant noted, ‘‘I came for
the money, but I stayed for the love.’’
The findings of this study are subject to limitations. The
use of baseline measures as predictors does not allow us to
test the associations between changes in predisposing or
enabling characteristics and the likelihood of study visit
nonattendance over time. As already noted, no comparison
group exists, limiting our ability to assess casual relation-
ships between retention strategies (positive or negative) and
visit attendance. Furthermore, retention strategies were not
assessed for their individual contribution to retention. Fu-
ture studies would be improved by the addition of a cost-
effectiveness component that allows for the assessment of
the individual and combined contribution of retention
strategies, as well as the relative labor-intensity. In addition,
participants were recruited from high poverty areas using
venue-based sampling and are not representative of all
women living in these communities or all women at-risk for
HIV. Findings from this study may not be generalizable to
other US states or cities.
In summary, the HPTN 064 study demonstrated that it is
possible to achieve high retention rates amongst a population
of women at increased risk for study discontinuation; it is
likely that the use of a multifaceted approach contributed to
this success, although the retention of women in studies is a
dynamic, iterative process. Based on our collective experi-
ence, we found that the strategies described in this article
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were associated with outstanding retention rates. Studies
enrolling similar populations may consider the following:
1. Engage community in all stages of study develop-
ment and implementation;
2. Invest extensive face time to develop trusting rela-
tionships with study participants early in study par-
ticipation;
3. Collect detailed locator information which includes
permission to contact participants through multiple
modalities and update frequently;
4. Be as flexible as possible regarding the day/time of study
visits and location, and when possible, visit windows;
5. Develop community partnerships and provide refer-
rals for situations that may affect study participation,
but are outside of the scope of the study (e.g.,
homelessness, substance use);
6. Use multiple retention approaches and modify re-
tention strategies throughout implementation based
on site experience;
7. Follow incarcerated participants if protocol allows;
8. Continue tracing efforts for hard to reach participants
throughout study implementation;
9. Provide staff with the training and resources needed
implement retention strategies;
10. Develop systems to assess the relative cost-effectiveness
of different retention strategies.
Such retention efforts require substantial commitment
by study funders and research sites and significant human
and fiscal resources but such efforts support reaching ac-
curate study results through high retention and may apply
more broadly to the retention of similar populations of
women in non-HIV related clinical trials as well as in
clinical care. Methods to maximize study participant re-
tention must be considered during the study planning
process.
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